Frederick R Ueland

Title: Frederick R Ueland: Innovator in Ovarian Cancer Biomarkers

Introduction

Frederick R Ueland is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian cancer. His work focuses on developing innovative biomarkers that can aid in the classification and diagnosis of ovarian cancer.

Latest Patents

Ueland holds a patent for "Biomarkers for Ovarian Cancer." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers developed by Ueland can classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. These biomarkers can be detected using SELDI mass spectrometry, showcasing a significant advancement in cancer diagnostics.

Career Highlights

Throughout his career, Ueland has worked with prominent organizations such as Vermillion Corporation and the University of Kentucky Research Foundation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Ueland's notable coworkers include Eric Thomas Fung and J R Van Nagell. Their collaborative efforts have furthered the understanding and development of ovarian cancer diagnostics.

Conclusion

Frederick R Ueland's innovative work in the field of ovarian cancer biomarkers highlights his commitment to improving patient outcomes through advanced medical technology. His contributions are invaluable in the ongoing fight against cancer.